Bio Rad Laboratories Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Perfect. Good afternoon, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at JPMorgan. It's my pleasure to introduce our next company, Bio-Rad. So this session will be a 40-minute fireside chat. (Operator Instructions)
And with that, we can get started. So thank you, Norman, and Ilan and Andy for joining us today. To kick it off, we could just talk about, in general, the strength that you guys have seen in the past 2 years.
Questions & Answers
So the strength that you guys have seen has been in partly due to strong contribution from COVID-related sales. So with new variants likely to continue to emerge, how should we be thinking about the durability of your revenue in the coming year? And then what do you see for '23 and beyond?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
